201 related articles for article (PubMed ID: 16420044)
1. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
3. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.
Harrison RJ; Cuesta J; Chessari G; Read MA; Basra SK; Reszka AP; Morrell J; Gowan SM; Incles CM; Tanious FA; Wilson WD; Kelland LR; Neidle S
J Med Chem; 2003 Oct; 46(21):4463-76. PubMed ID: 14521409
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493
[TBL] [Abstract][Full Text] [Related]
5. Selective recognition of G-qQuadruplex telomeric DNA by a bis(quinacridine) macrocycle.
Teulade-Fichou MP; Carrasco C; Guittat L; Bailly C; Alberti P; Mergny JL; David A; Lehn JM; Wilson WD
J Am Chem Soc; 2003 Apr; 125(16):4732-40. PubMed ID: 12696891
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
[TBL] [Abstract][Full Text] [Related]
7. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors.
Schultes CM; Guyen B; Cuesta J; Neidle S
Bioorg Med Chem Lett; 2004 Aug; 14(16):4347-51. PubMed ID: 15261300
[TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.
Mergny JL; Lacroix L; Teulade-Fichou MP; Hounsou C; Guittat L; Hoarau M; Arimondo PB; Vigneron JP; Lehn JM; Riou JF; Garestier T; Hélène C
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3062-7. PubMed ID: 11248032
[TBL] [Abstract][Full Text] [Related]
10. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
11. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
12. G-quadruplexes as therapeutic targets.
Neidle S; Read MA
Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
[TBL] [Abstract][Full Text] [Related]
13. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
[TBL] [Abstract][Full Text] [Related]
14. [G-quadruplex DNA: myth or reality?].
Riou JF; Gomez D; Lemarteleur T; Trentesaux C
Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
[TBL] [Abstract][Full Text] [Related]
15. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase.
Guyen B; Schultes CM; Hazel P; Mann J; Neidle S
Org Biomol Chem; 2004 Apr; 2(7):981-8. PubMed ID: 15034620
[TBL] [Abstract][Full Text] [Related]
17. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
[TBL] [Abstract][Full Text] [Related]
18. Porphyrin derivatives for telomere binding and telomerase inhibition.
Dixon IM; Lopez F; Estève JP; Tejera AM; Blasco MA; Pratviel G; Meunier B
Chembiochem; 2005 Jan; 6(1):123-32. PubMed ID: 15551357
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of G-quadruplex DNA and inhibition of telomerase activity by square-planar nickel(II) complexes.
Reed JE; Arnal AA; Neidle S; Vilar R
J Am Chem Soc; 2006 May; 128(18):5992-3. PubMed ID: 16669641
[TBL] [Abstract][Full Text] [Related]
20. Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.
Missailidis S; Stanslas J; Modi C; Ellis MJ; Robins RA; Laughton CA; Stevens MF
Oncol Res; 2002; 13(3):175-89. PubMed ID: 12549627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
